文献速递产科母胎医学

产前皮质类固醇与27-30月龄儿童神经发育的关联:一项基于人群的队列研究

Associations of Antenatal Corticosteroids With Neurodevelopment in Children Aged 27-30 Months: A Population-Based Cohort Study.
PubMed 文献 · BJOG · 2025-02-19

苏格兰2011年1月1日至2017年12月31日出生的285637名单胎儿童,在27-30月龄接受健康评估。调整混杂后,产前皮质类固醇暴露与28-33周出生儿童神经发育担忧减少相关(OR=0.79,95%CI=0.62-0.999),与34-36周出生儿童担忧增加相关(OR=1.11,95%CI=1.01-1.21),足月儿无独立关联,各胎龄组ASQ-3评分均无关联。

要点

  • 产前皮质类固醇暴露与28-33周出生儿童神经发育担忧减少相关(OR=0.79,95%CI=0.62-0.999)。
  • 产前皮质类固醇暴露与34-36周出生儿童神经发育担忧增加相关(OR=1.11,95%CI=1.01-1.21)。
  • 足月儿中未发现产前皮质类固醇暴露与神经发育的独立关联,各胎龄组ASQ-3评分均无关联。

核心结论

  • 在早期儿童中,产前皮质类固醇暴露与28-33周出生儿童神经发育担忧统计学显著减少相关,与34-36周出生儿童神经发育担忧统计学显著增加相关,但效应量小。
  • 足月出生儿童中未发现产前皮质类固醇暴露与神经发育的独立关联。

研究设计与样本

  • 基于人群的队列研究,纳入苏格兰2011年1月1日至2017年12月31日出生、胎龄28-41周的单胎儿童285637名,均在27-30月龄接受健康评估。
  • 采用 logistic 和线性回归分析,按出生胎龄(28-33、34-36、37-38和39-41周)分层,并调整母亲年龄、体重指数、糖尿病、产前吸烟、产次、邻里剥夺、出生年份、儿童性别和评估时年龄。

主要发现

  • 调整协变量后,产前皮质类固醇暴露与28-33周出生儿童神经发育担忧减少相关(OR=0.79,95%CI=0.62-0.999)。
  • 调整协变量后,产前皮质类固醇暴露与34-36周出生儿童神经发育担忧增加相关(OR=1.11,95%CI=1.01-1.21)。
  • 在更晚胎龄出生的儿童中未出现独立关联。
  • 产前皮质类固醇暴露与任何胎龄组的ASQ-3评分均无关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the associations of antenatal corticosteroid (ACS) exposure with neurodevelopment in early childhood, and how these vary with gestational age at birth. DESIGN: Population-based cohort study. SETTING: Scotland, UK. POPULATION: 285 637 singleton children born at 28-41 weeks' gestation, between 1st January 2011 and 31st December 2017, who underwent health reviews at 27-30 months of age. METHODS: Logistic and linear regression analyses, stratified by gestation at birth (28-33, 34-36, 37-38 and 39-41 weeks' gestation), were used to evaluate the associations between ACS exposure and neurodevelopmental outcomes, and adjusted for maternal age, body mass index, diabetes, antenatal smoking, parity, neighbourhood deprivation, birth year, child sex and age at review. MAIN OUTCOME MEASURES: Practitioner-identified concerns about any neurodevelopmental domain, and the average of five domain scores on neurodevelopmental milestones from the parent-rated Ages and Stages Questionnaire (ASQ-3). RESULTS: After adjustment for covariates, ACS exposure was associated with reduced neurodevelopmental concerns in children born at 28-33 weeks' gestation (OR = 0.79, 95% CI = 0.62-0.999) and with increased neurodevelopmental concerns in children born at 34-36 weeks' gestation (OR = 1.11, 95% CI = 1.01-1.21). No independent associations emerged in children born at later gestations. ACS exposure was not associated with ASQ-3 scores in any gestational age group. CONCLUSIONS: In early childhood, ACS exposure was associated with statistically significantly reduced neurodevelopmental concerns in children born at 28-33 weeks' gestation, and with statistically significantly increased neurodevelopment concerns in children born at 34-36 weeks' gestation. However, the effect sizes of these associations were small. No independent associations were found between ACS exposure and neurodevelopment in term-born children.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Frier EM, Lahti-Pulkkinen M, Lin C, et al. Associations of Antenatal Corticosteroids With Neurodevelopment in Children Aged 27-30 Months: A Population-Based Cohort Study. BJOG. 2025. PMID: 39971868. doi:10.1111/1471-0528.18101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。